Pharmaceutical

Novo Nordisk engages Thermo Fisher to produce weight-loss drug

Novo Nordisk has engaged Thermo Fisher as a contract manufacturer to produce the weight-loss drug, Wegovy (semaglutide), Reuters reported.

Aug 26, 2023 - 20:00
Novo Nordisk engages Thermo Fisher to produce weight-loss drug
Novo Nordisk has engaged Thermo Fisher as a contract manufacturer to produce the weight-loss drug, Wegovy (semaglutide), Reuters reported.
Read the original article

Tags:

Previous Article

Pfizer’s first-ever bispecific antibody Elrexfio holds promise in multiple myeloma

Next Article

FDA grants clearance to Gilead Sciences’ sNDA for Veklury

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Datopotamab deruxtecan by Daiichi Sankyo for Metastatic...

Apr 23, 2024

UK MHRA grants marketing authorisation for argenx’s gMG therapy

UK MHRA grants marketing authorisation for argenx’s gMG...

Mar 19, 2023

Johnson & Johnson seeks FDA approval for Tremfya for Crohn’s disease

Johnson & Johnson seeks FDA approval for Tremfya for Cr...

Jun 22, 2024